Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

NCT03683719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hand Eczema

Interventions

DRUG: Delgocitinib cream
DRUG: Delgocitinib cream vehicle

Sponsor

LEO Pharma